Omeros Corporation (OMER)

[1hb]

Doc Thorfin, Thanks! I agree on your assessments basically....in my question to you Sat. morning I estimated market for first kidney disease in clinical now should put market cap to 6 or 7 times the 24 price or over 100 on that alone plus eye product sales for this year....I do show ceo with just under 2 million shares which would be near 5% instead of 10%...am I off on his amount or total shares out? ....it makes no difference to your point he would not want to dilute but I just like to have my facts in line...since we knew the kidney clinical worked it was just a matter of time and breaktrough gets us off and running again..thanks for your insights on all the medical potentials you understand so well....keep up the great work...oh, did see where four more officers or directors filed with sec friday and looks to me like they each exercised options to buy 10,000 shares each but at 23.75 which I don't get since they don't expire until next year..am I reading that wrong on sec forms...maybe it just was awarding them the options at this price but I don't think so..anybody help on what they did? thanks